drug
anthrax vaccine
Marketedupdated 3mo agoby $EBS Emergent BioSolutions Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying anthrax vaccine
- phase1NasoShield Study of Safety and Immunogenicity
- phase2Ciprofloxacin BioThrax Co-Administration Study
- phase3Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults
- phase1Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults
- phase3VELOCITY: An Anthrax Vaccine Clinical Study
- phase2A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that